GlycoMimetics Statistics

Total Valuation

GlycoMimetics has a market cap or net worth of $20.00 million. The enterprise value is $7.15 million.

Market Cap	20.00M
Enterprise Value	7.15M

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

GlycoMimetics has 64.48 million shares outstanding. The number of shares has increased by 6.56% in one year.

Current Share Class	64.48M
Shares Outstanding	64.48M
Shares Change (YoY)	+6.56%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	3.15%
Owned by Institutions (%)	16.22%
Float	47.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.87
P/TBV Ratio	1.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	715.02
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.62, with a Debt / Equity ratio of 0.02.

Current Ratio	3.62
Quick Ratio	3.33
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -137.20% and return on invested capital (ROIC) is -77.67%.

Return on Equity (ROE)	-137.20%
Return on Assets (ROA)	-66.74%
Return on Capital (ROIC)	-77.67%
Revenue Per Employee	$286
Profits Per Employee	-$1.14M
Employee Count	35
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -77.24% in the last 52 weeks. The beta is 1.84, so GlycoMimetics's price volatility has been higher than the market average.

Beta (5Y)	1.84
52-Week Price Change	-77.24%
50-Day Moving Average	0.24
200-Day Moving Average	0.97
Relative Strength Index (RSI)	49.57
Average Volume (20 Days)	60,968,153

Short Selling Information

The latest short interest is 5.64 million, so 8.74% of the outstanding shares have been sold short.

Short Interest	5.64M
Short Previous Month	1.83M
Short % of Shares Out	8.74%
Short % of Float	11.79%
Short Ratio (days to cover)	1.07

Income Statement

In the last 12 months, GlycoMimetics had revenue of $10,000 and -$39.74 million in losses. Loss per share was -$0.62.

Revenue	10,000
Gross Profit	10,000
Operating Income	-36.78M
Pretax Income	-39.11M
Net Income	-39.74M
EBITDA	-36.73M
EBIT	-36.78M
Loss Per Share	-$0.62

Full Income Statement

Balance Sheet

The company has $14.39 million in cash and $262,133 in debt, giving a net cash position of $14.13 million or $0.22 per share.

Cash & Cash Equivalents	14.39M
Total Debt	262,133
Net Cash	14.13M
Net Cash Per Share	$0.22
Equity (Book Value)	11.38M
Book Value Per Share	0.18
Working Capital	11.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$35.01 million and capital expenditures -$10,773, giving a free cash flow of -$35.02 million.

Operating Cash Flow	-35.01M
Capital Expenditures	-10,773
Free Cash Flow	-35.02M
FCF Per Share	-$0.54

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-367,847.59%
Pretax Margin	-397,350.46%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-357,190.33%

Dividends & Yields

GlycoMimetics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.56%
Shareholder Yield	-6.56%
Earnings Yield	-186.73%
FCF Yield	-164.58%

Analyst Forecast

The average price target for GlycoMimetics is $12.00, which is 3,769.72% higher than the current price. The consensus rating is "Hold".

Price Target	$12.00
Price Target Difference	3,769.72%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	404.16%
EPS Growth Forecast (5Y)	-24.51%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1